TrialBMJ open2021

Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trial.

Victoria McCreanor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.